Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Journal of Vocational Rehabilitation ; : 1-7, 2023.
Article in English | Academic Search Complete | ID: covidwho-2305647

ABSTRACT

The Americans with Disabilities Act (ADA) is sweeping civil rights legislation that affords people with disabilities equality of opportunity, economic self-sufficiency, independent living, and full participation in daily life. The protections of the ADA extend to individuals with alcohol and substance abuse disorders who are in recovery.The objective of this article is to understand the ADA's definition of disability and how it applies to addiction and recovery. The reader will recognize how the ADA applies to people with addiction to alcohol and those in recovery from substance abuse. The article will describe the rights and responsibilities employers and employees have in the three stages of employment.The material in this presentation was developed based on the authors' research, training, education, knowledge, and skill of the ADA.Individuals in recovery are often unaware of their civil rights under the ADA. The ADA ensures that people with disabilities, including those with alcohol use disorder and substance use disorders, have the same rights and opportunities in the workplace.The COVID-19 pandemic has resulted in an increase in increased rates of alcoholism and substance abuse. Individuals living with addiction are unaware of the employment protections they may have under the ADA. Title I of the ADA guarantees employment protections to ensure equality in the workplace for people with disabilities. A clearer understanding of the law will ensure that job seekers and employees are treated in an ethical, valued, and courteous way when disclosing disability and the need for accommodation. [ FROM AUTHOR] Copyright of Journal of Vocational Rehabilitation is the property of IOS Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

2.
SLAS Technol ; 2023 Apr 28.
Article in English | MEDLINE | ID: covidwho-2304697

ABSTRACT

The potential immunogenicity of therapeutic human and humanized monoclonal antibodies (mAb) is a significant concern, and so preclinical testing of therapeutic mAbs routinely includes assessment of anti-drug antibody (ADA) induction. Here, we report the development of automated screening and confirmatory bridging ELISAs for the detection of rat antibodies against DH1042, an engineered human mAb for the SARS-CoV-2 receptor-binding domain. The assays were evaluated for specificity, sensitivity, selectivity, absence of a prozone effect, linearity, intra- and inter- assay precision, and robustness, and found to be suitable for purpose. The assays were then used to evaluate anti-DH1042 antibodies in the sera of rats dosed with lipid-nanoparticle (LNP)-encapsulated mRNA encoding DH1042. Rats received two doses of 0.1, 0.4 or 0.6 mg/kg/dose LNP-mRNA 8 days apart. Twenty-one days after the second dose, 50-100% of rats had developed confirmed anti-DH1042 ADA depending on dose level. No animals in the control group developed anti-DH1042 ADA. These assays reflect new applications for a non-specialized laboratory automation platform, and the methodologies and approaches reported here provide a template that can be adapted for the automated detection and confirmation of ADA in preclinical testing of other biologics.

3.
7th International Conference on Parallel, Distributed and Grid Computing, PDGC 2022 ; : 176-180, 2022.
Article in English | Scopus | ID: covidwho-2283508

ABSTRACT

The pandemic Covid-19 is a name coined by WHO on 31st December 2019. This devastating illness was carried on by a new coronavirus known as SARS-COV-2. Most of the research has focused on estimating the total number of cases and mortality rate of COVID-19. Due to this, people across the world were stressed out by observing the growing number of cases every day. As a means of maintaining equilibrium, this paper aims to identify the best way to predict the number of recovered cases of Coronavirus in India. Dataset was divided into two parts: training and testing. The training dataset utilised 70% of the dataset, and the testing dataset utilised 30%. In this paper, we applied 10 machine learning techniques i.e. Random Forest Classifier (RF), Naive Bayes (NB), Quadratic Discriminant Analysis (QDA), Gradient Boosting Classifier (GBM), Linear Discriminant Analysis (LDA), Logistic Regression (LR), K Neighbour Classifier (KNN), Decision Tree Classifier (DT), SVM - Linear and Ada-Boost Classifier in order to predict recovered patients in India. Our study suggests that Random Forest Classifier outperforms other machine learning models for predicting the recovered Coronavirus patients having an accuracy of 0.9632, AUC of 0.9836, Recall of 0.9640, Precision of 0.9680, F1 Score of 0.9617 and Kappa of 0.9558. © 2022 IEEE.

4.
Univers Access Inf Soc ; : 1-16, 2021 Aug 21.
Article in English | MEDLINE | ID: covidwho-2252212

ABSTRACT

This study explores whether US post-secondary institutions (PPI) follow philosophies to foster inclusive communities, providing resources for those individuals with disabilities thrive socially, personally, and academically, while there have been no thorough studies conducted to determine web accessibility of the nation's top-ranked PPI library webpages. Additionally, this study pioneers in comparison with the accessibility of PPI's library homepages fighting COVID-19. The study evaluated the library homepages of the premium PPIs based on Money.com's 2019 list of "The Best Colleges in America" via the WAVE web accessibility evaluation tool. The outcomes determined that most of the library homepages analyzed were littered with numerous errors, and the shift to online-based research in learning had no significant impact on the number of errors WAVE detected. The disconcerting findings of this study demonstrate the overall failure to recognize the importance of web accessibility or perhaps even the indifference toward accessibility on the part of the PPI community.

5.
Front Immunol ; 14: 1138609, 2023.
Article in English | MEDLINE | ID: covidwho-2260212

ABSTRACT

Despite numerous clinically available vaccines and therapeutics, aged patients remain at increased risk for COVID-19 morbidity. Furthermore, various patient populations, including the aged can have suboptimal responses to SARS-CoV-2 vaccine antigens. Here, we characterized vaccine-induced responses to SARS-CoV-2 synthetic DNA vaccine antigens in aged mice. Aged mice exhibited altered cellular responses, including decreased IFNγ secretion and increased TNFα and IL-4 secretion suggestive of TH2-skewed responses. Aged mice exhibited decreased total binding and neutralizing antibodies in their serum but significantly increased TH2-type antigen-specific IgG1 antibody compared to their young counterparts. Strategies to enhance vaccine-induced immune responses are important, especially in aged patient populations. We observed that co-immunization with plasmid-encoded adenosine deaminase (pADA)enhanced immune responses in young animals. Ageing is associated with decreases in ADA function and expression. Here, we report that co-immunization with pADA enhanced IFNγ secretion while decreasing TNFα and IL-4 secretion. pADA expanded the breadth and affinity SARS-CoV-2 spike-specific antibodies while supporting TH1-type humoral responses in aged mice. scRNAseq analysis of aged lymph nodes revealed that pADA co-immunization supported a TH1 gene profile and decreased FoxP3 gene expression. Upon challenge, pADA co-immunization decreased viral loads in aged mice. These data support the use of mice as a model for age-associated decreased vaccine immunogenicity and infection-mediated morbidity and mortality in the context of SARS-CoV-2 vaccines and provide support for the use of adenosine deaminase as a molecular adjuvant in immune-challenged populations.


Subject(s)
COVID-19 , SARS-CoV-2 , Humans , Animals , Mice , COVID-19 Vaccines , Tumor Necrosis Factor-alpha , Interleukin-4 , Adenosine Deaminase , Immunization , Antibodies, Viral , Disease Models, Animal
6.
HIV Nursing ; 22(2):3217-3220, 2022.
Article in English | Scopus | ID: covidwho-2164654

ABSTRACT

Introduction and background: Adenosine deaminase (ADA) is an enzyme produced from body cells after infections due to activations of the immune response toward the microbes. The enzyme was previously used for the diagnosis of tuberculosis, lymphomas, sarcoidosis, lupus, and severe combined immunodeficiency (SCID). COVID-19 is a viral disease caused by Coronaviruses and infected the respiratory tract of patients mainly. The aim of this study is to measure and correlate the level of ADA with COVID-19 during the infection, patient and methods: Two methods;conventional enzymatic (Guisti and Galanti method) and ELISA methods were used to measure the level of ADA in 48 individuals, 12 were suffering from severe COVID-19, 12 has a moderate infection and 24 individuals were used as the control they are negative PCR- COVID-19 infections. Results: Both methods show that the level of ADA in patients suffering from COVID-19 infection is significantly higher in patients with severe infections compared with those in control and moderate infections' P <0.001, conclusion: This study concluded that the use of ADA levels in the serum of COVID-19 patients will be useful during the period of the disease. © 2022, HIV Nursing. All rights reserved.

7.
Microbiol Spectr ; : e0286622, 2022 Oct 26.
Article in English | MEDLINE | ID: covidwho-2088449

ABSTRACT

The polysaccharide capsule of Cryptococcus neoformans-an opportunistic basidiomycete pathogen and the major etiological agent of fungal meningoencephalitis-is a key virulence factor that prevents its phagocytosis by host innate immune cells. However, the complex signaling networks for their synthesis and attachment remain elusive. In this study, we systematically analyzed capsule biosynthesis and signaling networks using C. neoformans transcription factor (TF) and kinase mutant libraries under diverse capsule-inducing conditions. We found that deletion of GAT201, YAP1, BZP4, and ADA2 consistently caused capsule production defects in all tested media, indicating that they are capsule-regulating core TFs. Epistatic and expression analyses showed that Yap1 and Ada2 control Gat201 upstream, whereas Bzp4 and Gat201 independently regulate capsule production. Next, we searched for potential upstream kinases and found that mutants lacking PKA1, BUD32, POS5, IRE1, or CDC2801 showed reduced capsule production under all three capsule induction conditions, whereas mutants lacking HOG1 and IRK5 displayed enhanced capsule production. Pka1 and Irk5 controlled the induction of GAT201 and BZP4, respectively, under capsule induction conditions. Finally, we monitored the transcriptome profiles governed by Bzp4, Gat201, and Ada2 under capsule-inducing conditions and demonstrated that these TFs regulate redundant and unique sets of downstream target genes. Bzp4, Ada2, and Gat201 govern capsule formation in C. neoformans by regulating the expression of various capsule biosynthesis genes and chitin/chitosan synthesis genes in a positive and negative manner, respectively. In conclusion, this study provides further insights into the complex regulatory mechanisms of capsule production-related signaling pathways in C. neoformans. IMPORTANCE Over the past decades, human fungal pathogens, including C. neoformans, have emerged as a major public threat since the AIDS pandemic, only to gain more traction in connection to COVID-19. Polysaccharide capsules are rare fungal virulence factors that are critical for protecting C. neoformans from phagocytosis by macrophages. To date, more than 75 proteins involved in capsule synthesis and cell wall attachment have been reported in C. neoformans; however, their complex upstream signaling networks remain elusive. In this study, we demonstrated that Ada2, Yap1, Bzp4, and Gat201 were key capsule-inducing transcriptional regulators. Yap1 and Ada2 function upstream of Gat201, whereas Bzp4 and Gat201 function independently. Genome-wide transcriptome profiling revealed that Bzp4, Gat201, and Ada2 promote capsule production and attachment by positively and negatively regulating genes involved in capsule synthesis and chitin/chitosan synthesis, respectively. Thus, this study provides comprehensive insights into the complex capsule-regulating signaling pathway in C. neoformans.

8.
2nd IEEE International Conference on Intelligent Technologies, CONIT 2022 ; 2022.
Article in English | Scopus | ID: covidwho-2029208

ABSTRACT

In this paper, the relationship between COVID-19 Maximum Infection Rate (MIR) and the happiness indicators has been investigated for the prediction of Happiness Score of Countries using Random Forest (RF) algorithm. The per-formance of the proposed algorithm is also compared against five other algorithms such as Linear Regression (LR), Ada Boost Classifier (ABC), K-Nearest Neighbor (KNN), Gaussian Naive Bayes (NB) and Logistic Regression. The comparison of performance includes parameters like training accuracy, testing accuracy and computation time. It is clear from the observation that the proposed approach is superior to others. Then the parameters like MAE, MSE, RMSE, R2 Score, Adjusted R2 Score is calculated. This proposed algorithm can be used for other classification and regression work involving large amount of data with missing values like COVID- 19 datasets. © 2022 IEEE.

9.
2022 IEEE International Conference on Distributed Computing and Electrical Circuits and Electronics, ICDCECE 2022 ; 2022.
Article in English | Scopus | ID: covidwho-1932103

ABSTRACT

As a critical constituent of many institutions domestic safety and protection precedence, surveillance has mounted its significance and advantages several instances with the aid of using offering instant supervising of possessions, humans having access to your private home and property. This project deals with the layout method of an Embedded Real-Time automated door lock safety device the use of pi digital camera primarily based totally on Raspberry Pi 3 for intruder remark that enhances surveillance generation to offer critical safety to homes and related control. An embedded internet server creates a clean manner for tracking & routinely locking the door any device. The Raspberry Pi primarily based totally Automatic Door Un-locking system the use of a pi Camera affords the concept of tracking a selected area in a far flung vicinity and stumble on the unknown face if they are attempting to enter. The door gets unlock only when it detects the known face and switches on the home lights as home application. When unknown or unauthorized person's face is detected, this device will ship SMS and the picture of the unauthorized person is sent to the owner's mail. The diligent of contemporary COVID-19 situation. As temperature test performs crucial position in controlling unfold of covid, the proposed project has an extra characteristic of temperature test of the individual that attempts to go into the house. So, it has even temperature sensor and LCD which will ask the person to measure his temperature and display the temperature, the measured temperature is also send to cloud so that owner can view the person temperature. © 2022 IEEE.

10.
Pandemics and Global Health ; : 341-351, 2021.
Article in English | Scopus | ID: covidwho-1918602

ABSTRACT

The present world is witnessing a pandemic disease caused by a new strain of corona virus called COVID-19.The new strain of corona virus has got a worldwide attention and affected directly or indirectly almost whole of the world population. It is a serious respiratory viral disease by SARS-CoV-2 appeared as a pandemic at the end of 2019 in China.Though several preventive vaccines to lessen the cases of serious hospitalizations have already been developed, a specific drug against COVID-19 is still under research. This emerging health crisis calls for the urgent development of specific therapeutics to fight against COVID-19 to reduce the burden of this pandemic. Medicinal plants are getting more recognition in the present scenario due to the non availability of synthetic medicines. We have identified certain important active compounds from selected medicinal plants, used in Ayurveda with proven anti viral properties, like Holostemma-adakodien, Barleria strigosa and Canscora perfoliata as a part of our research on screening active constituents. In the present paper anti-viral activity of certain identified compounds from the selected plants by molecular docking method against COVID-19 was collected. The identified compounds such as 7-hydroxy-6-methoxycoumarin (scopoletin), 3, 4-dihydroxycinnamic acid (caffeic acid), 3, 3', 4', 5, 7-pentahydroxyflavone (quercetin), (2S, 3R)-2-(3, 4-dihydroxyphenyl) chroman-3, 5, 7-triol (catechin), 3-caffeoylquinic acid (chlorogenic acid), mangiferin and palmatine were selected for the present study. The identified compounds were found very effective in inhibiting the new corona virus as per the studies conducted. This comprehensive review will hopefully pave a way for development of phytoconstituent based antiviral therapeutic agent for treatment or prevention of COVID-19. © 2022 by Nova Science Publishers, Inc.

11.
Transp Res Part A Policy Pract ; 159: 84-95, 2022 May.
Article in English | MEDLINE | ID: covidwho-1829590

ABSTRACT

Paratransit services developed under the Americans with Disabilities Act are a critical transportation means for persons with disabilities to meet their basic needs, but the COVID-19 pandemic posed an unprecedented challenge to service providers. To safeguard transportation equity, this study used complete records of service trips and riders obtained from the Access Transportation Program in the Seattle region for an empirical analysis aimed at answering two research questions. First, how did the ridership and trip purposes of paratransit change after the outbreak of COVID-19? Second, what factors explained the users' changing levels of service usage in response to the pandemic? Statistical methods, including a Hurdle model, were employed as the analytical tools. The results show that paratransit ridership dramatically decreased during 2020 with the most substantial reductions of working and non-essential personal trips, and that most of the remaining trips were for medical purposes. The results also indicate that riders' service usage during the pandemic was associated with their sociodemographic characteristics, disability conditions, and pre-pandemic travel demand. When controlling for other factors, riders who lived in neighborhoods with lower income and lower access to personal vehicles were more dependent on the service. Based on the empirical findings, we recommend that when developing plans for future disruptive events, public transit agencies should promptly implement safety measures, identify and prioritize neighborhoods that are most in need of mobility services, and actively pursue collaboration with other organizations for innovative service delivery options.

12.
Int J Gen Med ; 14: 4011-4016, 2021.
Article in English | MEDLINE | ID: covidwho-1360675

ABSTRACT

BACKGROUND: Diabetes risk score can be used as a simple non-invasive screening tool for identifying people with high risk of diabetes. This study aimed to assess the predictive power of various risk-scoring systems to predict pre-diabetes and diabetes in Jordanian adults. METHODS: This cross-sectional study was conducted among people attending 54 primary health care centers distributed throughout the 12 governorates of Jordan. Diabetes risk scores using the American Diabetes Association risk score, Canadian risk score, Finland risk score (FINDRISC), British Risk score, German and Australian risk score were calculated for each patient. Fasting blood sugar (FBS) was measured for all participants. RESULTS: This study included 392 participants: 231 patients with normal fasting blood sugar (FBG), 101 patients with pre-diabetes and 60 patients with type 2 diabetes. The FINDRISC, British, and Australian risk scores were strongly inter-correlated and weakly correlated with other systems' risk scores. Moreover, they correlated moderately and significantly with FBS. In contrast, other systems risk scores were associated weekly with FBS. Based on receiving operating characteristics (ROC) analysis and multivariate logistic regression, the FINDRISC risk score was superior to other risk scores to predict high FBS and identify pre-diabetes and diabetes. CONCLUSION: FINDRISC risk score performed the best compared to other risk scores for predicting pre-diabetes, diabetes, and absence of diabetes. We recommend using the FINDRISC risk score assessment in Jordan.

13.
J Law Med Ethics ; 49(2): 293-302, 2021.
Article in English | MEDLINE | ID: covidwho-1354058

ABSTRACT

Employers and governments are interested in the use of serological (antibody) testing to allow people to return to work before there is a vaccine for SARS-CoV-2. We articulate the preconditions needed for the implementation of antibody testing, including the role of the U.S. Food & Drug Administration.


Subject(s)
COVID-19 Serological Testing , COVID-19 , COVID-19 Testing , COVID-19 Vaccines , Employment , Humans , SARS-CoV-2
14.
Comput Struct Biotechnol J ; 19: 2833-2850, 2021.
Article in English | MEDLINE | ID: covidwho-1240272

ABSTRACT

The worldwide health crisis caused by the SARS-Cov-2 virus has resulted in>3 million deaths so far. Improving early screening, diagnosis and prognosis of the disease are critical steps in assisting healthcare professionals to save lives during this pandemic. Since WHO declared the COVID-19 outbreak as a pandemic, several studies have been conducted using Artificial Intelligence techniques to optimize these steps on clinical settings in terms of quality, accuracy and most importantly time. The objective of this study is to conduct a systematic literature review on published and preprint reports of Artificial Intelligence models developed and validated for screening, diagnosis and prognosis of the coronavirus disease 2019. We included 101 studies, published from January 1st, 2020 to December 30th, 2020, that developed AI prediction models which can be applied in the clinical setting. We identified in total 14 models for screening, 38 diagnostic models for detecting COVID-19 and 50 prognostic models for predicting ICU need, ventilator need, mortality risk, severity assessment or hospital length stay. Moreover, 43 studies were based on medical imaging and 58 studies on the use of clinical parameters, laboratory results or demographic features. Several heterogeneous predictors derived from multimodal data were identified. Analysis of these multimodal data, captured from various sources, in terms of prominence for each category of the included studies, was performed. Finally, Risk of Bias (RoB) analysis was also conducted to examine the applicability of the included studies in the clinical setting and assist healthcare providers, guideline developers, and policymakers.

15.
Bioanalysis ; 13(9): 669-674, 2021 May.
Article in English | MEDLINE | ID: covidwho-1227121

ABSTRACT

As part of the European Bioanalysis Forum mission to provide development opportunities for scientists, a Young Scientist Symposium has been organized every year since 2014. The meetings, organized by and for young scientists, aim at immersing talent from industry and academia in the scientific and process challenges important for their (future) professional environment. In an ideal world, the setting of an interactive symposium in stimulating auditorium sets the foundation for long lasting peer scientific relationship. This year, a pandemic has descended across all continents, changing the dynamics of the meeting. This manuscript summarizes the discussions at the Sixth EBF Young Scientist Symposium, originally planned as a face-to face event in March 2020 in Bologna, Italy but finally executed as a hybrid meeting in Cyberspace and on location in a few regions across Europe between 24-25 September 2020.


Subject(s)
Biological Assay , Research Personnel , Europe , Feedback , Humans
18.
Saf Sci ; 131: 104920, 2020 Nov.
Article in English | MEDLINE | ID: covidwho-695362

ABSTRACT

With the 2019 emergence of coronavirus disease 19 (colloquially called COVID-19) came renewed public concern about airborne and aerosolized virus transmission. Accompanying this concern were many conflicting dialogues about which forms of personal protective equipment best protect dental health care practitioners and their patients from viral exposure. In this comprehensive review we provide a thorough and critical assessment of face masks and face shields, some of the most frequently recommended personal safeguards against viral infection. We begin by describing the function and practicality of the most common mask types used in dentistry: procedural masks, surgical masks, and filtering respirator facemasks (also called N95s). This is followed by a critical assessment of mask use based on a review of published evidence in three key domains: the degree to which each mask type is shown to protect against airborne and aerosolized disease, the reported likelihood for non-compliance among mask users, and risk factors associated with both proper and improper mask use. We use this information to conclude our review with several practical, evidence-based recommendations for mask use in dental and dental educational clinics.

SELECTION OF CITATIONS
SEARCH DETAIL